<DOC>
	<DOCNO>NCT02693938</DOCNO>
	<brief_summary>This research study design look difference responsiveness subcutaneous injection standardize dose rapid-acting insulin analog blood glucose variability different phase menstrual cycle female type 1 diabetes ( T1D ) .</brief_summary>
	<brief_title>Blood Glucose Variability Insulin Action During Menstrual Cycle Females With Type 1 Diabetes</brief_title>
	<detailed_description>Type 1 Diabetes ( T1D ) chronic disease lead disability premature death well treat . While female male equally affect T1D , diabetes place additional burden care female . Characteristically , females T1D bad glycemic control , high incidence diabetic ketoacidosis , great risk cardiovascular complication compare male peer . It hypothesize variation responsiveness pre-meal bolus dos insulin menstrual cycling important underlying cause increase management problem females T1D , hypothesis adequately test . Consequently , insulin treatment female different cycle menstruation remain guessing game often result major swing blood glucose high low level . The unfavorable impact gap knowledge extend efficiency accuracy artificial pancreas closed-loop ( CL ) system insulin delivery algorithm design base insulin action parameter . The propose study address unmet need diabetes management female open-loop ( OL ) CL therapy .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Age 1235 2. diagnosis T1D &gt; 1year ; 3 . BMI % &lt; 85th ; 4 . HbA1c &lt; 9 % . 5 . Subjects age 2135y combination oral contraceptive pill ( OCP ) could include . 1. irregular period , 2. pregnant , breastfeeding , 3. subject &gt; 20y progesterone pill injection , 4 . Likelihood require treatment study period drug permit study protocol , 5. mental condition render subject unable understand nature , scope possible consequence study , include blood glucose monitoring requirement include documentation blood glucose data insulin dosing , and/or inability return followup visit , unlikely complete study . 6 . Subjects OCP exclude 1220y group capture physiologic variability insulin action pubertal progress .</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>diabetes</keyword>
	<keyword>menstrual cycle</keyword>
	<keyword>insulin</keyword>
</DOC>